Integrin Receptor Antagonist drugs

4 medications in the FDA established pharmacologic class “Integrin Receptor Antagonist”.

DrugTypeNDC products
Entyvio
Vedolizumab
Rx2
ENTYVIO Pen
Vedolizumab
Rx1
Tyruko
Natalizumab-sztn
Rx1
Tysabri
Natalizumab
Rx1